Azitra (AZTR) Long-Term Deferred Tax (2022 - 2026)
Azitra (AZTR) posted Long-Term Deferred Tax of $119951.0 for Q1 2026, down 82.36% on a QoQ basis from $679908.0 in Q4 2025, and down 80.66% year-over-year from $620253.0 in Q1 2025.
Azitra (AZTR) Long-Term Deferred Tax (2022 - 2026) Analysis & Trends
Azitra's Long-Term Deferred Tax history runs 5 years deep, the most recent figure standing at $119951.0 for Q1 2026.
- Quarterly Long-Term Deferred Tax fell 80.66% year-over-year to $119951.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119951.0 (down 80.66% YoY) and the FY2025 annual result came in at $679908.0, up 14.5% from the prior year.
- Long-Term Deferred Tax was $119951.0 for Q1 2026 at Azitra, down from $679908.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $920001.0 in Q2 2023 and bottomed at $119951.0 in Q1 2026.
- A 5-year average of $674928.1 and a median of $680594.0 in 2025 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2025 — Long-Term Deferred Tax advanced 26.88% — and 2026, when it slumped 80.66%.
- Azitra's Long-Term Deferred Tax stood at $800831.0 in 2022, then decreased by 7.32% to $742229.0 in 2023, then retreated by 20.0% to $593802.0 in 2024, then advanced by 14.5% to $679908.0 in 2025, then tumbled by 82.36% to $119951.0 in 2026.
- Business Quant data shows AZTR's Long-Term Deferred Tax at $119951.0 in Q1 2026, $679908.0 in Q4 2025, and $680594.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,951.00 |
| Dec 31, 2025 | 679,908.00 |
| Sep 30, 2025 | 680,594.00 |
| Jun 30, 2025 | 644,505.00 |
| Mar 31, 2025 | 620,253.00 |
| Dec 31, 2024 | 593,802.00 |
| Sep 30, 2024 | 536,390.00 |
| Jun 30, 2024 | 882,223.00 |
| Mar 31, 2024 | 816,578.00 |
| Dec 31, 2023 | 742,229.00 |
| Sep 30, 2023 | 736,800.00 |
| Jun 30, 2023 | 920,001.00 |
| Dec 31, 2022 | 800,831.00 |